These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28365260)

  • 1. CXCL12 as a Predictor of Vitiligo Activity and Disease Progression.
    Alexeev V
    J Invest Dermatol; 2017 Jul; 137(7):1588-1590. PubMed ID: 28365260
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations of CXCL12 in Serum of Patients with Vitiligo.
    Speeckaert R; Ongenae K; van Geel N
    J Invest Dermatol; 2017 Jul; 137(7):1586-1588. PubMed ID: 28238843
    [No Abstract]   [Full Text] [Related]  

  • 3. Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression.
    Rezk AF; Kemp DM; El-Domyati M; El-Din WH; Lee JB; Uitto J; Igoucheva O; Alexeev V
    J Invest Dermatol; 2017 May; 137(5):1126-1134. PubMed ID: 28132854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of disease activity in vitiligo: A systematic review.
    Speeckaert R; Speeckaert M; De Schepper S; van Geel N
    Autoimmun Rev; 2017 Sep; 16(9):937-945. PubMed ID: 28698094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile of genes associated with the dopamine pathway in vitiligo skin biopsies and blood sera.
    Reimann E; Kingo K; Karelson M; Reemann P; Loite U; Keermann M; Abram K; Vasar E; Silm H; Kõks S
    Dermatology; 2012; 224(2):168-76. PubMed ID: 22572099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The majority of patients presenting with vitiligo have a clinical sign of activity.
    Aboul-Fettouh N; Hinojosa J; Tovar-Garza A; Pandya AG
    J Am Acad Dermatol; 2017 Oct; 77(4):774-775. PubMed ID: 28917464
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Significance of Serum Soluble CD Molecules to Assess Disease Activity in Vitiligo.
    Speeckaert R; Lambert J; van Geel N
    JAMA Dermatol; 2016 Nov; 152(11):1194-1200. PubMed ID: 27556155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of ischemia-modified albumin in predicting oxidative stress in patients with vitiligo.
    Ataş H; Kocabıyık M; Gönül M; Öztürk Y; Kavutçu M
    Biomark Med; 2017 May; 11(6):439-449. PubMed ID: 28598198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased systemic and epidermal levels of IL-17A and IL-1β promotes progression of non-segmental vitiligo.
    Bhardwaj S; Rani S; Srivastava N; Kumar R; Parsad D
    Cytokine; 2017 Mar; 91():153-161. PubMed ID: 28082234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship Between the Serum Level of Vitamin D and Vitiligo: A Controlled Study on 300 Subjects.
    Khurrum H; AlGhamdi KM
    J Cutan Med Surg; 2016; 20(2):139-45. PubMed ID: 26458407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo.
    Vaccaro M; Cannavò SP; Imbesi S; Cristani M; Barbuzza O; Tigano V; Gangemi S
    Int J Dermatol; 2015 Jun; 54(6):672-4. PubMed ID: 25427848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study before and after narrow band (311 nm) UVB treatment in vitiligo.
    De Francesco V; Stinco G; Laspina S; Parlangeli ME; Mariuzzi L; Patrone P
    Eur J Dermatol; 2008; 18(3):292-6. PubMed ID: 18474458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a relationship between homocysteine and vitiligo? A pilot study.
    Shaker OG; El-Tahlawi SM
    Br J Dermatol; 2008 Sep; 159(3):720-4. PubMed ID: 18616781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients.
    Shang Z; Li H
    J Dermatol; 2017 Oct; 44(10):1138-1144. PubMed ID: 28500632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation products are increased in patients affected by non-segmental generalized vitiligo.
    Vaccaro M; Bagnato G; Cristani M; Borgia F; Spatari G; Tigano V; Saja A; Guarneri F; Cannavò SP; Gangemi S
    Arch Dermatol Res; 2017 Aug; 309(6):485-490. PubMed ID: 28551758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed vitiligo in childhood: a study on 13 Italian patients.
    Neri I; Russo T; Piccolo V; Patrizi A
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e140-1. PubMed ID: 22364176
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic value of elevated CXCR4 and CXCL12 in neonatal sepsis.
    Tunc T; Cekmez F; Cetinkaya M; Kalayci T; Fidanci K; Saldir M; Babacan O; Sari E; Erdem G; Cayci T; Kul M; Kavuncuoglu S
    J Matern Fetal Neonatal Med; 2015 Feb; 28(3):356-61. PubMed ID: 24749796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM-CSF: a possible prognostic serum biomarker of vitiligo patients' considered for transplantation treatment with cultured autologous melanocytes: a pilot study.
    Wu XG; Hong WS; Xu A
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1409-11. PubMed ID: 26514995
    [No Abstract]   [Full Text] [Related]  

  • 19. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo.
    Onsun N; Büyükbabani N; Ummetoğlu O; Cebeci F
    J Dermatol; 2009 Nov; 36(11):612-5. PubMed ID: 19878396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.
    van Geel NA; Mollet IG; De Schepper S; Tjin EP; Vermaelen K; Clark RA; Kupper TS; Luiten RM; Lambert J
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):375-84. PubMed ID: 20370855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.